Skip to main content

Advertisement

Table 2 Distribution of antimalarial drugs and co-medication prescribed by facility

From: Adherence to treatment guidelines for uncomplicated malaria at two public health facilities in Nigeria; Implications for the ‘test and treat’ policy of malaria case management

Antimalarial drugs Total facility n (%) NAUMC Awka n (%) NAUTH Nnewi n (%) Chi square difference P = value
Artemisinin-based combinations (ACTs) 2027 (93) 1198 (95) 829 (91) 13.02 0.0003***
  Artemether-lumefantrin 1024 (50.5) 647 (54) 377 (45.5) - -
  Artesunate-amodiaquine 244 (12) 206 (17.2) 38 (4.5) - -
  Artesunate-mefloquine 232 (11.5) - 232 (28) - -
  Artesunate-pyridoxine + pyrimethamine 188 (9.3) 56 (4.7) 132 (16) - -
  Dihydroartemisinin-piperaquine 339 (16.7) 289 (24.1) 50 (6) - -
Mono-therapy 144 (7) 63 (5) 81 (9) 13.02 0.0003***
  Artesunate 42 (29.2) 7 (11.1) 35 (43.2) - -
  Amodiaquine 14 (9.7) - 14 (17.3) - -
  Proguanil 15 (10.4) 1 (1.6) 14 (17.3) - -
  Quinine 6 (4.2) 6 (9.5) - - -
  Sulphadoxine + pyrimethamine 67 (46.5) 49 (77.8) 18 (22.2) - -
Proportion of co-medication n (%) 1722 (97) 1248 (99) 864 (95) 32.37 0.0001***
  Analgesics 1722 (79) 1124 (89) 598 (66) 176.8 0.0001***
  Vitamin preparations 1364 (63) 993 (79) 371 (41) 324.8 0.0001***
  Antibiotics 1084 (50) 721 (57) 363 (40) 63.18 0.0001***
  1. ***= very significant.